alosetron has been researched along with tandospirone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asagarasu, A; Hayashi, H; Matsui, T; Minato, K; Sato, M; Tamaoki, S; Yamauchi, Y | 1 |
1 other study(ies) available for alosetron and tandospirone
| Article | Year |
|---|---|
Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.
Topics: Administration, Oral; Animals; Biological Availability; Brain; Cell Line; Cricetinae; Cricetulus; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Irritable Bowel Syndrome; Muscle Contraction; Muscle, Smooth; Piperazines; Pyridines; Quinazolinones; Quinolines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Reflex; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Stereoisomerism; Structure-Activity Relationship | 2010 |